Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Rheumatoid Arthritis

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 88 articles:
HTML format



Single Articles


    January 2021
  1. PTACEK J, Hawtin RE, Sun D, Louie B, et al
    Diminished cytokine-induced Jak/STAT signaling is associated with rheumatoid arthritis and disease activity.
    PLoS One. 2021;16:e0244187.
    PubMed     Abstract available


  2. BECART S, Whittington KB, Prislovsky A, Rao NL, et al
    The role of posttranslational modifications in generating neo-epitopes that bind to rheumatoid arthritis-associated HLA-DR alleles and promote autoimmune T cell responses.
    PLoS One. 2021;16:e0245541.
    PubMed     Abstract available


  3. DIAZ-RUBIO GI, Corona-Meraz FI, Madrigal-Ruiz PM, Robles-De Anda JA, et al
    CCR2/CCL2 and CMKLR1/RvE1 chemokines system levels are associated with insulin resistance in rheumatoid arthritis.
    PLoS One. 2021;16:e0246054.
    PubMed     Abstract available


  4. LEDON-LLANES L, Contreras-Yanez I, Guaracha-Basanez G, Valverde-Hernandez SS, et al
    Views of Mexican outpatients with rheumatoid arthritis on sexual and reproductive health: A cross-sectional study.
    PLoS One. 2021;16:e0245538.
    PubMed     Abstract available


  5. GALVEZ-SANCHEZ CM, de la Coba P, Colmenero JM, Reyes Del Paso GA, et al
    Attentional function in fibromyalgia and rheumatoid arthritis.
    PLoS One. 2021;16:e0246128.
    PubMed     Abstract available


  6. DISSANAYAKE K, Jayasinghe C, Wanigasekara P, Sominanda A, et al
    Potential applicability of cytokines as biomarkers of disease activity in rheumatoid arthritis: Enzyme-linked immunosorbent spot assay-based evaluation of TNF-alpha, IL-1beta, IL-10 and IL-17A.
    PLoS One. 2021;16:e0246111.
    PubMed     Abstract available


  7. GAURAV R, Mikuls TR, Thiele GM, Nelson AJ, et al
    High-throughput analysis of lung immune cells in a combined murine model of agriculture dust-triggered airway inflammation with rheumatoid arthritis.
    PLoS One. 2021;16:e0240707.
    PubMed     Abstract available


  8. SHUKLA R, Ganeshani M, Agarwal M, Jangir R, et al
    Dehydroepiandrostenedione sulphate (DHEAS) levels predict high risk of rheumatoid arthritis (RA) in subclinical hypothyroidism.
    PLoS One. 2021;16:e0246195.
    PubMed     Abstract available



  9. Expression of Concern: Functional Improvement of Regulatory T Cells from Rheumatoid Arthritis Subjects Induced by Capsular Polysaccharide Glucuronoxylomannogalactan.
    PLoS One. 2021;16:e0247971.
    PubMed    


  10. GOSSELT HR, Vallerga CL, Mandaviya PR, Lubberts E, et al
    Epigenome wide association study of response to methotrexate in early rheumatoid arthritis patients.
    PLoS One. 2021;16:e0247709.
    PubMed     Abstract available


  11. DONNELLY S, Wilson AG, Mannan H, Dix C, et al
    (In)Visible illness: A photovoice study of the lived experience of self-managing rheumatoid arthritis.
    PLoS One. 2021;16:e0248151.
    PubMed     Abstract available


  12. DREVINGE C, Scheffler JM, Koro-Arvidsson C, Sundh D, et al
    Intermediate monocytes correlate with CXCR3+ Th17 cells but not with bone characteristics in untreated early rheumatoid arthritis.
    PLoS One. 2021;16:e0249205.
    PubMed     Abstract available


  13. SLOT LM, Vergroesen RD, Kerkman PF, Staudinger E, et al
    Light chain skewing in autoantibodies and B-cell receptors of the citrullinated antigen-binding B-cell response in rheumatoid arthritis.
    PLoS One. 2021;16:e0247847.
    PubMed     Abstract available



  14. Correction to Expression of Concern on: Functional Improvement of Regulatory T Cells from Rheumatoid Arthritis Subjects Induced by Capsular Polysaccharide Glucuronoxylomannogalactan.
    PLoS One. 2021;16:e0249512.
    PubMed     Abstract available


  15. PAGLIA MDG, Silva MT, Lopes LC, Barberato-Filho S, et al
    Use of corticoids and non-steroidal anti-inflammatories in the treatment of rheumatoid arthritis: Systematic review and network meta-analysis.
    PLoS One. 2021;16:e0248866.
    PubMed     Abstract available


  16. KUR-ZALEWSKA J, Kisiel B, Kania-Pudlo M, Tlustochowicz M, et al
    A dose-dependent beneficial effect of methotrexate on the risk of interstitial lung disease in rheumatoid arthritis patients.
    PLoS One. 2021;16:e0250339.
    PubMed     Abstract available


  17. DONNELLY S, Wilson AG, Mannan H, Dix C, et al
    Correction: (In)Visible illness: A photovoice study of the lived experience of self-managing rheumatoid arthritis.
    PLoS One. 2021;16:e0250451.
    PubMed     Abstract available


  18. LIN CT, Huang WN, Tsai WC, Chen JP, et al
    Predictors of drug survival for biologic and targeted synthetic DMARDs in rheumatoid arthritis: Analysis from the TRA Clinical Electronic Registry.
    PLoS One. 2021;16:e0250877.
    PubMed     Abstract available


  19. TATANGELO M, Tomlinson G, Paterson JM, Keystone E, et al
    Health care costs of rheumatoid arthritis: A longitudinal population study.
    PLoS One. 2021;16:e0251334.
    PubMed     Abstract available


  20. KATO M, Ikeda K, Sugiyama T, Tanaka S, et al
    Associations of ultrasound-based inflammation patterns with peripheral innate lymphoid cell populations, serum cytokines/chemokines, and treatment response to methotrexate in rheumatoid arthritis and spondyloarthritis.
    PLoS One. 2021;16:e0252116.
    PubMed     Abstract available


  21. LEE DH, Sheen SH, Lee DG, Jang JW, et al
    Association between ischemic stroke and seropositive rheumatoid arthritis in Korea: A nationwide longitudinal cohort study.
    PLoS One. 2021;16:e0251851.
    PubMed     Abstract available


  22. MATSUMOTO Y, Takahashi K, Sugioka Y, Inui K, et al
    Double-blinded randomized controlled trial to reveal the effects of Brazilian propolis intake on rheumatoid arthritis disease activity index; BeeDAI.
    PLoS One. 2021;16:e0252357.
    PubMed     Abstract available


  23. FRAENKEL L, Wei Z, Ramsey C, Wiedmeyer C, et al
    OPEX: Development of a novel overall patient experience measure to facilitate interpretation of comparison effectiveness studies.
    PLoS One. 2021;16:e0245598.
    PubMed     Abstract available


  24. NIK-AZIS NM, Mohd N, Mohd Fadzilah F, Mohamed Haflah NH, et al
    Rheumatoid arthritis serotype and synthetic disease-modifying anti-rheumatic drugs in patients with periodontitis: A case-control study.
    PLoS One. 2021;16:e0252859.
    PubMed     Abstract available


  25. REPAC J, Mandic M, Lunic T, Bozic B, et al
    Mining the capacity of human-associated microorganisms to trigger rheumatoid arthritis-A systematic immunoinformatics analysis of T cell epitopes.
    PLoS One. 2021;16:e0253918.
    PubMed     Abstract available


  26. KALWEIT M, Walker UA, Finckh A, Muller R, et al
    Personalized prediction of disease activity in patients with rheumatoid arthritis using an adaptive deep neural network.
    PLoS One. 2021;16:e0252289.
    PubMed     Abstract available


  27. DEYAB G, Reine TM, Vuong TT, Jenssen T, et al
    Antirheumatic treatment is associated with reduced serum Syndecan-1 in Rheumatoid Arthritis.
    PLoS One. 2021;16:e0253247.
    PubMed     Abstract available


  28. TAKESHITA A, Nishida K, Yoshida A, Nasu Y, et al
    RANKL expression in chondrocytes and its promotion by lymphotoxin-alpha in the course of cartilage destruction during rheumatoid arthritis.
    PLoS One. 2021;16:e0254268.
    PubMed     Abstract available


  29. JAYARAM M, Wang C, Wang L, Chung KC, et al
    Validating the Michigan Hand Outcomes Questionnaire in patients with rheumatoid arthritis using Rasch analysis.
    PLoS One. 2021;16:e0254984.
    PubMed     Abstract available


  30. MOON SJ, Jhun J, Ryu J, Kwon JY, et al
    The anti-arthritis effect of sulforaphane, an activator of Nrf2, is associated with inhibition of both B cell differentiation and the production of inflammatory cytokines.
    PLoS One. 2021;16:e0245986.
    PubMed     Abstract available


  31. RASKER JJ, Wolfe F, Klaver-Krol EG, Zwarts MJ, et al
    The relation of fibromyalgia and fibromyalgia symptoms to self-reported seizures.
    PLoS One. 2021;16:e0246051.
    PubMed     Abstract available


  32. MINAMINO H, Katsushima M, Hashimoto M, Fujita Y, et al
    Influence of dietary habits on depression among patients with rheumatoid arthritis: A cross-sectional study using KURAMA cohort database.
    PLoS One. 2021;16:e0255526.
    PubMed     Abstract available


  33. LIN PH, Yu SF, Chen JF, Chen YC, et al
    Risk factor analysis of fragility fractures in rheumatoid arthritis: A 3-year longitudinal, real-world, observational, cohort study.
    PLoS One. 2021;16:e0255542.
    PubMed     Abstract available


  34. KUMAR SK, Arya S, Singh A, Misra R, et al
    Patterns of T and B cell responses to Mycobacterium tuberculosis membrane-associated antigens and their relationship with disease activity in rheumatoid arthritis patients with latent tuberculosis infection.
    PLoS One. 2021;16:e0255639.
    PubMed     Abstract available


  35. TRIKHA R, Greig D, Sekimura T, Cevallos N, et al
    Active rheumatoid arthritis in a mouse model is not an independent risk factor for periprosthetic joint infection.
    PLoS One. 2021;16:e0250910.
    PubMed     Abstract available


  36. GONZALEZ-PONCE F, Gamez-Nava JI, Perez-Guerrero EE, Saldana-Cruz AM, et al
    Serum chemerin levels: A potential biomarker of joint inflammation in women with rheumatoid arthritis.
    PLoS One. 2021;16:e0255854.
    PubMed     Abstract available


  37. CHI C, Taylor KE, Quach H, Quach D, et al
    Hypomethylation mediates genetic association with the major histocompatibility complex genes in Sjogren's syndrome.
    PLoS One. 2021;16:e0248429.
    PubMed     Abstract available


  38. KHALED SAA, Mahmoud HFF
    Platelet indices parameters in the new disease activity score of rheumatoid arthritis with ankle involvement: A comparative analytic study.
    PLoS One. 2021;16:e0257200.
    PubMed     Abstract available


  39. KARYDIS A, Sandal I, Luo J, Prislovsky A, et al
    Influence of the shared epitope on the elicitation of experimental autoimmune arthritis biomarkers.
    PLoS One. 2021;16:e0250177.
    PubMed     Abstract available


  40. DIAZ-GALLO LM, Brynedal B, Westerlind H, Sandberg R, et al
    Understanding interactions between risk factors, and assessing the utility of the additive and multiplicative models through simulations.
    PLoS One. 2021;16:e0250282.
    PubMed     Abstract available


  41. TURESSON WADELL A, Barebring L, Hulander E, Gjertsson I, et al
    Effects on health-related quality of life in the randomized, controlled crossover trial ADIRA (Anti-inflammatory Diet In Rheumatoid Arthritis).
    PLoS One. 2021;16:e0258716.
    PubMed     Abstract available


  42. NAKAE K, Masui S, Yonezawa A, Hashimoto M, et al
    Potential application of measuring serum infliximab levels in rheumatoid arthritis management: A retrospective study based on KURAMA cohort data.
    PLoS One. 2021;16:e0258601.
    PubMed     Abstract available


  43. LIU W, Ma W, Liu H, Li C, et al
    Stroke risk in arthritis: A systematic review and meta-analysis of cohort studies.
    PLoS One. 2021;16:e0248564.
    PubMed     Abstract available


  44. SHIBATA K, Yoshimura A, Ikeuchi S, Ishii M, et al
    Effectiveness of drug safety measures for reducing the incidence of adverse drug reactions: Post-hoc analysis of data from all-case surveillance of iguratimod using generalized estimating equations.
    PLoS One. 2021;16:e0253513.
    PubMed     Abstract available


  45. DOS SANTOS LP, Santo RCDE, Ramis TR, Portes JKS, et al
    The effects of resistance training with blood flow restriction on muscle strength, muscle hypertrophy and functionality in patients with osteoarthritis and rheumatoid arthritis: A systematic review with meta-analysis.
    PLoS One. 2021;16:e0259574.
    PubMed     Abstract available


  46. MATSUMOTO H, Fujita Y, Asano T, Matsuoka N, et al
    Association between inflammatory cytokines and immune-checkpoint molecule in rheumatoid arthritis.
    PLoS One. 2021;16:e0260254.
    PubMed     Abstract available


  47. KAWAHITO Y, Takakubo Y, Morinobu A, Matsubara N, et al
    Patient satisfaction, preferences, expectations, characteristics, and impact of suboptimal control of rheumatoid arthritis: A subgroup analysis of Japanese patients from a large international cohort study (SENSE).
    PLoS One. 2021;16:e0259389.
    PubMed     Abstract available


  48. GVOZDJAKOVA A, Sumbalova Z, Kucharska J, Szamosova M, et al
    Platelet mitochondrial respiration and coenzyme Q10 could be used as new diagnostic strategy for mitochondrial dysfunction in rheumatoid diseases.
    PLoS One. 2021;16:e0256135.
    PubMed     Abstract available


  49. SEMBLER-MOLLER ML, Belstrom D, Locht H, Pedersen AML, et al
    Combined serum anti-SSA/Ro and salivary TRIM29 reveals promising high diagnostic accuracy in patients with primary Sjogren's syndrome.
    PLoS One. 2021;16:e0258428.
    PubMed     Abstract available


  50. MARRIE RA, Walld R, Bolton JM, Sareen J, et al
    Effect of comorbid mood and anxiety disorders on breast and cervical cancer screening in immune-mediated inflammatory disease.
    PLoS One. 2021;16:e0249809.
    PubMed     Abstract available


    January 2020
  51. PAN Y, Norton S, Gwinnutt JM, Kearsley-Fleet L, et al
    Correction: Not all moderate disease is the same - Identification of disability trajectories among patients with rheumatoid arthritis and moderate disease activity.
    PLoS One. 2020;15:e0231481.
    PubMed     Abstract available


  52. KHATRI S, Hansen J, Astakhova K
    Antibodies to synthetic citrullinated peptide epitope correlate with disease activity and flares in rheumatoid arthritis.
    PLoS One. 2020;15:e0232010.
    PubMed     Abstract available


  53. AVOUAC J, Cauvet A, Steelandt A, Shirai Y, et al
    Improving risk-stratification of rheumatoid arthritis patients for interstitial lung disease.
    PLoS One. 2020;15:e0232978.
    PubMed     Abstract available


  54. MOON J, Choi SH, Yoon CH, Kim MK, et al
    Gut dysbiosis is prevailing in Sjogren's syndrome and is related to dry eye severity.
    PLoS One. 2020;15:e0229029.
    PubMed     Abstract available


  55. UMEKITA K, Hashiba Y, Iwao K, Iwao C, et al
    Human T-cell leukemia virus type 1 may invalidate T-SPOT.TB assay results in rheumatoid arthritis patients: A retrospective case-control observational study.
    PLoS One. 2020;15:e0233159.
    PubMed     Abstract available


  56. KOLARZ B, Ciesla M, Dryglewska M, Rosenthal AK, et al
    Hypermethylation of the miR-155 gene in the whole blood and decreased plasma level of miR-155 in rheumatoid arthritis.
    PLoS One. 2020;15:e0233897.
    PubMed     Abstract available


  57. SACRISTAN JA, Dilla T, Diaz-Cerezo S, Gabas-Rivera C, et al
    Patient-physician discrepancy in the perception of immune-mediated inflammatory diseases: rheumatoid arthritis, psoriatic arthritis and psoriasis. A qualitative systematic review of the literature.
    PLoS One. 2020;15:e0234705.
    PubMed     Abstract available


  58. ALAM J, Lee A, Lee J, Kwon DI, et al
    Dysbiotic oral microbiota and infected salivary glands in Sjogren's syndrome.
    PLoS One. 2020;15:e0230667.
    PubMed     Abstract available


  59. CASANOVA-VALLVE N, Constantin-Teodosiu D, Filer A, Hardy RS, et al
    Skeletal muscle dysregulation in rheumatoid arthritis: Metabolic and molecular markers in a rodent model and patients.
    PLoS One. 2020;15:e0235702.
    PubMed     Abstract available


  60. BAGHDADI LR
    Effect of methotrexate use on the development of type 2 diabetes in rheumatoid arthritis patients: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0235637.
    PubMed     Abstract available


  61. JIRSOVA K, Seidler Stangova P, Palos M, Mahelkova G, et al
    Aberrant HLA-DR expression in the conjunctival epithelium after autologous serum treatment in patients with graft-versus-host disease or Sjogren's syndrome.
    PLoS One. 2020;15:e0231473.
    PubMed     Abstract available


  62. ORTIZ-HARO AB, Lerma-Talamantes A, Cabrera-Vanegas A, Contreras-Yanez I, et al
    Development and validation of a questionnaire assessing household work limitations (HOWL-Q) in women with rheumatoid arthritis.
    PLoS One. 2020;15:e0236167.
    PubMed     Abstract available


  63. XINQIANG S, Erqin D, Yu Z, Hongtao D, et al
    Potential mechanisms of action of celastrol against rheumatoid arthritis: Transcriptomic and proteomic analysis.
    PLoS One. 2020;15:e0233814.
    PubMed     Abstract available


  64. DERAMBURE C, Dzangue-Tchoupou G, D'Agostino MA, Lequerre T, et al
    Gene expression regulated by abatacept associated with methotrexate and correlation with disease activity in rheumatoid arthritis.
    PLoS One. 2020;15:e0237143.
    PubMed     Abstract available


  65. VAN BOHEEMEN L, van Beers-Tas MH, Kroese JM, van de Stadt LA, et al
    Cardiovascular risk in persons at risk of developing rheumatoid arthritis.
    PLoS One. 2020;15:e0237072.
    PubMed     Abstract available


  66. ESBENSEN BA, Stallknecht SE, Madsen ME, Hagelund L, et al
    Correlations of fatigue in Danish patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis.
    PLoS One. 2020;15:e0237117.
    PubMed     Abstract available


  67. CONTRERAS-YANEZ I, Cabrera-Vanegas A, Robledo-Torres A, Caceres-Giles C, et al
    Association of significant risk perception with the use of complementary and alternative medicine: A cross-sectional study in Hispanic patients with rheumatoid arthritis.
    PLoS One. 2020;15:e0237504.
    PubMed     Abstract available


  68. BURISCH J, Eigner W, Schreiber S, Aletaha D, et al
    Risk for development of inflammatory bowel disease under inhibition of interleukin 17: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0233781.
    PubMed     Abstract available


  69. PINEL L, Perez-Nieto MA, Redondo M, Rodriguez-Rodriguez L, et al
    Emotional affection on a sustained attention task: The importance the aging process and depression.
    PLoS One. 2020;15:e0234405.
    PubMed     Abstract available


  70. FOSTER E, Malloy MJ, Jokubaitis VG, Wrede CDH, et al
    Increased risk of cervical dysplasia in females with autoimmune conditions-Results from an Australia database linkage study.
    PLoS One. 2020;15:e0234813.
    PubMed     Abstract available


  71. JUN JH, Lee YH, Son MJ, Kim H, et al
    Importance of tear volume for positivity of tear matrix metalloproteinase-9 immunoassay.
    PLoS One. 2020;15:e0235408.
    PubMed     Abstract available


  72. DI BENEDETTO P, Cipriani P, Iacono D, Pantano I, et al
    Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still's disease. Analysis of the multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort.
    PLoS One. 2020;15:e0235326.
    PubMed     Abstract available


  73. ASLAM MM, Jalil F, John P, Fan KH, et al
    A sequencing study of CTLA4 in Pakistani rheumatoid arthritis cases.
    PLoS One. 2020;15:e0239426.
    PubMed     Abstract available


  74. ARNTZ OJ, Pieters BCH, van Lent PLEM, Koenders MI, et al
    An optimized method for plasma extracellular vesicles isolation to exclude the copresence of biological drugs and plasma proteins which impairs their biological characterization.
    PLoS One. 2020;15:e0236508.
    PubMed     Abstract available


  75. JHUN J, Moon J, Ryu J, Shin Y, et al
    Liposome/gold hybrid nanoparticle encoded with CoQ10 (LGNP-CoQ10) suppressed rheumatoid arthritis via STAT3/Th17 targeting.
    PLoS One. 2020;15:e0241080.
    PubMed     Abstract available


  76. CHUANG CJ, Hsu CW, Lu MC, Koo M, et al
    Increased risk of developing dental diseases in patients with primary Sjogren's syndrome-A secondary cohort analysis of population-based claims data.
    PLoS One. 2020;15:e0239442.
    PubMed     Abstract available


  77. MATHEWS PM, Robinson SA, Gire A, Baer AN, et al
    Extraglandular ocular involvement and morbidity and mortality in primary Sjogren's Syndrome.
    PLoS One. 2020;15:e0239769.
    PubMed     Abstract available


  78. MORI S, Koga Y, Nakamura K, Hirooka S, et al
    Mortality in rheumatoid arthritis patients with pulmonary nontuberculous mycobacterial disease: A retrospective cohort study.
    PLoS One. 2020;15:e0243110.
    PubMed     Abstract available


  79. TEITSMA XM, Devenport J, Jacobs JWG, Petho-Schramm A, et al
    Comprehensive exploratory autoantibody profiling in patients with early rheumatoid arthritis treated with methotrexate or tocilizumab.
    PLoS One. 2020;15:e0241189.
    PubMed     Abstract available


  80. BAGHDADI LR
    Correction: Effect of methotrexate use on the development of type 2 diabetes in rheumatoid arthritis patients: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0243960.
    PubMed     Abstract available


  81. MORI A, Saito T, Takahashi M, Shibata M, et al
    Presence of anti-nuclear antibodies is a risk factor for the appearance of anti-drug antibodies during infliximab or adalimumab therapy in patients with rheumatoid arthritis.
    PLoS One. 2020;15:e0243729.
    PubMed     Abstract available


  82. DROZ N, Hanaway P, Hyman M, Jin Y, et al
    The impact of functional medicine on patient-reported outcomes in inflammatory arthritis: A retrospective study.
    PLoS One. 2020;15:e0240416.
    PubMed     Abstract available


  83. SHOJI J, Inada N, Tomioka A, Yamagami S, et al
    Assessment of mucin-related gene alterations following treatment with rebamipide ophthalmic suspension in Sjogren's syndrome-associated dry eyes.
    PLoS One. 2020;15:e0242617.
    PubMed     Abstract available


  84. GATT A, Mercieca C, Borg A, Grech A, et al
    Thermal characteristics of rheumatoid feet in remission: Baseline data.
    PLoS One. 2020;15:e0243078.
    PubMed     Abstract available


  85. KOO H, Morrow CD
    Perturbation of the human gastrointestinal tract microbial ecosystem by oral drugs to treat chronic disease results in a spectrum of individual specific patterns of extinction and persistence of dominant microbial strains.
    PLoS One. 2020;15:e0242021.
    PubMed     Abstract available


  86. BUSCHHART AL, Bolten L, Volzke J, Ekat K, et al
    Periodontal pathogens alter the synovial proteome. Periodontal pathogens do not exacerbate macroscopic arthritis but alter the synovial proteome in mice.
    PLoS One. 2020;15:e0242868.
    PubMed     Abstract available


  87. BEN-ELI H, Solomon A, Aframian DJ, Ben-Chetrit E, et al
    Serological and hematological characteristics of Sjogren's syndrome and dry eye syndrome patients using a novel immune serology technique.
    PLoS One. 2020;15:e0244712.
    PubMed     Abstract available


    January 2019
  88. MILIC V, Colic J, Cirkovic A, Stanojlovic S, et al
    Disease activity and damage in patients with primary Sjogren's syndrome: Prognostic value of salivary gland ultrasonography.
    PLoS One. 2019;14:e0226498.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: